← Open Payments lookup

JAMES SHAFFER: Open Payments

NPI 1104058387 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,595 in 160 payments from 17 companies in 2025. Trend: 2023 $2,100 · 2024 $2,321 · 2025 $2,595

Food & beverage: $2,496Education: $99
CompanyPaymentsAmount
ABBVIE INC.60$805
Janssen Biotech, Inc.20$415
GENZYME CORPORATION8$181
Madrigal Pharmaceuticals11$171
Gilead Sciences, Inc.13$162
Aimmune Therapeutics, Inc.9$139
Ipsen Biopharmaceuticals, Inc9$135
Takeda Pharmaceuticals U.S.A., Inc.5$117
QOL Medical, LLC4$104
PFIZER INC.5$93

Products named: RINVOQ, TREMFYA, DUPIXENT, CREON, REZDIFFRA, IQIRVO, Sucraid, LINZESS.

Industry payments across MD — which companies pay providers there.